PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
29-May-2020 Chi-Med Announces NDA Acceptance in China for Savolitinib in the Treatment of Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutations Chi-Med
29-May-2020 New number of shares and votes in Moberg Pharma AB (publ) Moberg Pharma
29-May-2020 Santhera Provides Update on the Ongoing Regulatory Review of Puldysa® (Idebenone) by the CHMP in Duchenne Muscular Dystrophy (DMD) Santhera Pharmaceuticals
29-May-2020 COVID-19 vaccine development: new guidelines for ethical approach to infecting trial volunteers University of Warwick
29-May-2020 First patient dosed in Achilles’ Phase I/II study in melanoma Syncona
28-May-2020 Peli BioThermal Expands Global Rental Network in Incheon, South Korea Peli BioThermal
28-May-2020 Sanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaboration Sanofi
28-May-2020 Nordic Nanovector ASA: Results for the First Quarter 2020 Nordic Nanovector
28-May-2020 Chi-Med and BeiGene Enter into Clinical Collaboration to Evaluate Combinations of Surufatinib and Fruquintinib with Tislelizumab Hutchison China MediTech Limited
28-May-2020 Inivata Announces Strategic Collaboration and Investment from NeoGenomics NeoGenomics, Inc.
28-May-2020 Cambridge Innovation Capital portfolio company Inivata announces strategic collaboration and investment from NeoGenomics Cambridge Innovation Capital
28-May-2020 Dupixent® (dupilumab) eosinophilic esophagitis trial meets both co-primary endpoints Regeneron
28-May-2020 Immunocore announces dosing of first patient with fourth ImmTAC® Immunocore
28-May-2020 Vectura provides AGM trading update and reiterates 2020 guidance Vectura
28-May-2020 New gut health and immunity white paper launched Clasado Biosciences
28-May-2020 Pneumagen Announces £4m Fundraising and Commits to Clinical Trial Development for COVID-19 Pneumagen
28-May-2020 Cytovation Announces Dosing of First Patient in its Phase I/II CICILIA Trial Investigating CyPep-1 in Patients with Solid Cancers Cytovation AS
28-May-2020 NuCana to Present at the 2020 Jefferies Virtual Healthcare Conference NuCana plc
28-May-2020 Oxitec’s New Friendly Aedes aegypti Mosquito Technology Receives Full Biosafety Approval in Brazil Oxitec Ltd
28-May-2020 Cidara Therapeutics Doses First Patient in Pivotal Phase 3 ReSPECT Trial of Rezafungin for Prevention of Invasive Fungal Disease in Patients Undergoing Allogeneic Blood and Marrow Transplantation Cidara Therapeutics, Inc